Europ J Comp Gastroent. 2000; 5
(2): 5–10.
Canine faecal pancreatic
elastase (cE1) in dogs with clinical exocrine pancreatic insufficiency,
normal dogs and dogs with chronic enteropathies.
Spillmann T, Wiberg ME, Teigelkamp S, Failing K, Chaudhry YS, Kirsch A,
Eifler R, Westermarck E, Eigenbrodt E, Sziegoleit A.
Faecal canine pancreatic elastase (cE1) concentration was measured in faeces
samples of dogs with clinical exocrine pancreatic insufficiency (EPI),
normal dogs of different breeds,normal Beagles, German Shepherd dogs (GSD),
Rough Coated Collies (RCC) and dogs with chronic enteropathies. Using single
day faeces samples median faecal cE1 concentration was 1.6 µg/g (0-18.0) in
dogs with clinical EPI, 253.2 µg/g (0-3952.0) in normal dogs, 618.2 µg/g
(6.6-2929.0) in Beagles, 49.0 µg/g (0-567.0) in GSD/RCC and 360.0 µg/g
(0-3472.0) in dogs with chronic enteropathies. Using faeces samples from
three consecutive days median faecal cE1 values were 1.3 µg/g (0-10.8) in
dogs with clinical EPI, 410.3 µg/g (111.0-1721.0) in Beagles, 49.0 µg/g
(1.9-567.0) in GSD/RCC and 262.0 µg/g (30.0-1694.0 µg/g in dogs with
enteropathies. It is concluded that faecal cE21 determination can be used to
diagnose or exclude clinical EPI in dogs with chronic diarrhea.